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ABSTRACT
The 30 cleavage generating non-polyadenylated
animal histone mRNAs depends on the base pairing
between U7 snRNA and a conserved histone pre-
mRNA downstream element. This interaction is
enhanced by a 100 kDa zinc finger protein (ZFP100)
that forms a bridge between an RNA hairpin element
upstream of the processing site and the U7 small
nuclear ribonucleoprotein (snRNP). The N-terminus
of Lsm11, a U7-specific Sm-like protein, was shown
to be crucial for histone RNA processing and to bind
ZFP100. By further analysing these two functions of
Lsm11, we find that Lsm11 and ZFP100 can undergo
two interactions, i.e. between the Lsm11 N-terminus
and the zinc finger repeats of ZFP100, and between
the N-terminus of ZFP100 and the Sm domain of
Lsm11, respectively. Both interactions are not spe-
cific for the two proteins in vitro, but the second inter-
action is sufficient for a specific recognition of the U7
snRNP by ZFP100 in cell extracts. Furthermore, clus-
tered point mutations in three phylogenetically con-
served regions of the Lsm11 N-terminus impair or
abolish histone RNA processing. As these mutations
have no effect on the two interactions with ZFP100,
these protein regions must play other roles in histone
RNA processing, e.g. by contacting the pre-mRNA or
additional processing factors.
INTRODUCTION
Histone RNA processing, an endonucleolytic cleavage reac-
tion generating non-polyadenylated mature mRNA 30 ends, is
one of the most important steps regulating the expression
of animal replication-dependent histone mRNAs [reviewed in
(1–3)]. As their name implies, the abundance of these mRNAs
is controlled in parallel with S phase and DNA synthesis in
metazoans. In mammalian cells, histone gene transcription is
regulated 5-fold. However, the most important contribution
to cell cycle regulation is made by post-transcriptional events.
Both RNA 30 end processing and histone mRNA stability
are cell cycle-regulated (4), and both of these regulatory
events are mainly controlled by the fluctuating abundance
of an RNA-binding protein (5) known as hairpin-binding pro-
tein (HBP) (6) or stem–loop binding protein (7). These post-
transcriptional controls allow for the concerted regulation of
all transcripts from 50 replication-dependent histone genes
that are encoded by mammalian genomes.
HBP binds to an RNA hairpin embedded in a 26 nt evolu-
tionarily conserved sequence that ends at the RNA cleavage
site. Thus, HBP can bind both to histone pre-mRNAs and to
mature mRNAs and thereby control both the nuclear pro-
cessing reaction and later cytoplasmic events [reviewed in
(2,3)]. The role of HBP in the processing reaction is to enhance
the binding of a second cleavage factor, the U7 small nuclear
ribonucleoprotein (snRNP), to another conserved pre-mRNA
sequence located a few nucleotides downstream of the pro-
cessing site (8–10). The U7 snRNP binds to this histone
downstream element (HDE) by RNA base pairing between
the 50 end of U7 snRNA and the histone pre-mRNA
(11,12). The extent of this base pairing is different for the
various non-allelic histone pre-mRNAs, and thus a stabiliza-
tion of this interaction by HBP may be very important for some
pre-mRNAs and less so for others (8,9,13).
How this additional tethering of the U7 snRNP to the his-
tone pre-mRNA by HBP may be achieved has become clearer
in recent years, owing to the identification and molecular
characterization of additional processing factors. On the one
hand, Dominski, Marzluff and co-workers (14) identified a
100 kDa protein containing 18 C2H2 zinc finger repeats
(ZFP100, also known as ZFN473 or KIAA1141 protein)
which can bind to an RNP complex consisting of HBP and
a histone RNA hairpin, but not to either component of
this complex alone. ZFP100 was shown to participate in the
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tethering of the U7 snRNP to the histone pre-mRNA
processing substrate, presumably by interacting with an
unidentified component of the U7 snRNP.
On the other hand, our laboratory has recently characterized
the polypeptide composition of the U7 snRNP. These studies
revealed that the U7 snRNP has a unique structure (15–17).
The spliceosomal U1, U2, U4 and U5 snRNPs each contain
seven small proteins, the Sm proteins B/B0, D1, D2, D3, E, F
and G (18,19). These Sm proteins, as well as the related
Sm-like (Lsm) proteins, contain two conserved amino acid
motifs (the Sm motifs 1 and 2) that form a specific tertiary
structure, the Sm fold or Sm domain [reviewed in (18)].
Moreover, the seven spliceosomal Sm proteins form a hep-
tameric ring that associates with a conserved U-rich single-
stranded sequence in the snRNAs, the so-called Sm-binding
site. This assembled ring is called the Sm core structure. In
comparison with the spliceosomal snRNAs, U7 snRNA has a
non-canonical Sm-binding site (20,21). Moreover, two of the
standard Sm proteins, D1 and D2, are replaced in its Sm core
structure by U7-specific Lsm proteins, Lsm10 and Lsm11
(15,16). Whereas the 14 kDa Lsm10 protein is a rather com-
mon member of the Sm/Lsm protein family, Lsm11 has an
unusual architecture. With 40 kDa (apparent molecular mass
on gels 45–50 kDa), it is very large for an Sm/Lsm protein.
This extra mass is found in a long N-terminal extension (170
amino acids) before and in a long intervening sequence (138
amino acids) between its two conserved Sm motifs. Interest-
ingly, the N-terminal region is dispensable for the specific
incorporation of the protein into the U7 Sm core but essential
for histone RNA processing (16). Additionally, we found that
this N-terminal region of Lsm11 can bind ZFP100 (16), indic-
ating that the additional tethering of the U7 snRNP is achieved
by the formation of a molecular bridge between HBP bound to
the histone hairpin, ZFP100, and Lsm11 which is a component
of the U7 snRNP [reviewed in (17)].
In the present study, we have more precisely characterized
the interaction between ZFP100 and Lsm11. In addition, we
wanted to know whether the N-terminus of Lsm11 contributes
to histone RNA processing only by its binding to ZFP100, or
whether a separate processing function can be identified. Sur-
prisingly, we find that Lsm11 and ZFP100 can engage in not
only one but in two distinct mutual interactions. The
N-terminus of Lsm11 binds to the zinc finger repeats of
ZFP100 but does not interact with an N-terminal part of
ZFP100 that is lacking zinc finger repeats. In contrast, this
N-terminal region of ZFP100 interacts with full-length (FL)
Lsm11, but also with an Lsm11 truncation mutant lacking the
N-terminal region or with the unrelated Sm D2 protein. This
indicates that this second interaction may be formed with Sm
domains in general. In cell extracts, this second interaction
is sufficient for a specific recognition between ZFP100 and
the U7 snRNP. Moreover, we have introduced clustered point
mutations in four evolutionarily conserved amino acid
stretches within the N-terminus of Lsm11. One of these muta-
tions strongly abrogates the ability of the protein to participate
in histone RNA processing, although the mutated protein can
still form an Sm core with U7 snRNA. Mutations in two other
motifs lead to a partial loss of processing activity. Interest-
ingly, these mutations do not affect the binding to ZFP100,
indicating that the corresponding motifs contribute to histone
RNA processing by a different mechanism.
MATERIALS AND METHODS
Plasmids
Murine Lsm11 clones. The following subclones of Lsm11
cDNA in the pcDNA3-HA vector (15) have been described
previously (16): HA-mLsm11FL (FL protein), HA-
mLsm11DN140 (first 140 amino acids deleted) and HA-
mLsm11Dsp77 (amino acids 246–322 deleted, i.e. a major part
of the spacer between the Sm motifs). The region encoding the
first 136 amino acids (up to a SmaI restriction site) was cloned
similarly into pcDNA3-HA to yield HA-mLsm11N136.
Clustered point mutations in conserved sequence motifs
within the N-terminus of Lsm11 (22) were created by a fusion
PCR strategy, resulting in the replacement of the tripeptides
PLL, YES, PER or MPL, respectively, by three consecutive
alanines. Each of these mutants was recloned into pcDNA3-
HA. These mutants were named according to their original
sequence (e.g. PLL, YES . . . ).
For bacterial expression, the regions encoding the first 136
amino acids of Lsm11 wild-type (wt) as well as the PLL, YES
and PER mutants were cloned into the pGex4T3 vector
(Amersham Bioscience). For the MPL mutant and an appro-
priate wt Lsm11 control, a region corresponding to the first
157 amino acids was amplified by PCR and similarly cloned
into pGex4T3.
Human ZFP100 clones. A pSP64 plasmid encoding human
ZFP100 (14) (a gift from Z. Dominski, UNC Chapel Hill)
was digested with NcoI or NcoI/XhoI, and appropriate restric-
tion fragments were cloned in the pIVEX2.4d vector (Roche)
for in vitro translation. Additional ZFP100 fragments to be
used for in vitro transcription/translation were generated by
PCR with Pfu DNA polymerase and cloned into the pCRII-
TOPO vector (Invitrogen). The primers used are shown in
Table 1. Each of the upstream primers contained a T7 RNA
polymerase promoter and an in-frame start codon (under-
lined). Downstream primers contained a translation stop
codon. The clones were cleaved with Asp718 I or EcoRV,
depending on the orientation of the insert, prior to in vitro
transcription/translation. For bacterial expression, an NcoI
fragment encoding the first 169 amino acids was cloned
into pGex4T3.
A clone encoding the Kid-1 zinc finger protein (ZFN354a)
from the rat in a pET-21a backbone (a gift from E. O’Leary
and J. V. Bonventre, Harvard Medical School) was used dir-
ectly for in vitro transcription/translation.
All clones were verified by DNA sequencing. Details of the
constructs are available on request.
Glutathione S-transferase (GST) pull-down assays
To study protein–protein interactions in vitro, recombinant
GST (negative control) or GST fusion proteins were isolated
from Escherichia coli BL21 Gold transfected with pGex4T3
(negative control) or with pGex4T3-derived plasmids contain-
ing either the wt sequence or different clustered point
mutations in the context of the Lsm11 N-terminus, or the
N-terminus of ZFP100. The purified proteins were coupled
to glutathione beads and incubated with [35S]methionine-
labelled proteins obtained by coupled in vitro transcription/
translation in rabbit reticulocyte lysate (TnT kit;
Promega). The in vitro translated proteins were encoded by
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pcDNA3-HA-derived plasmids for Lsm11 and by pIVEX2.4d-
or pCRII-TOPO-derived plasmids for ZFP100.
Each binding reaction contained 1.2 nmol of GST
(36 mg) or GST fusion protein (55 mg) and 65 fmol of
radiolabelled in vitro translated binding substrate (3.5–
4.1 ng). The beads and proteins were incubated in
phosphate-buffered saline (PBS) supplemented with 0.1%
NP40 at 4C for 2 h with gentle agitation on a wheel. Sub-
sequently, the beads were washed with PBS/NP40 and the
bound and input materials were analysed by SDS–PAGE
and detected on a Storm 820 PhosphorImager (Amersham).
Interaction studies of HA-tagged proteins in
293-T cell extracts
Human 293-T cells were cultured as described previously (15).
For transfection, they were grown to 50–60% confluency in
10 cm dishes and transfected with 10 mg of the pcDNA3-
HA-derived plasmids complexed with Lipofectamine (Life
Technologies). Cells were harvested 48 h post transfection.
The preparation of small-scale whole cell extracts, immuno-
precipitations and precipitations with biotinylated oligonuc-
leotides complementary to the 50 ends of U7 or U1 snRNA
were performed as described previously (15). In some experi-
ments, the extract from one 10 cm dish (100 ml) was incubated
with 100 mg of RNase A (Sigma) for 20 min at 30C prior to
immunoprecipitation. Proteins were resolved on 12% high-
TEMED SDS–polyacrylamide gels (23), analysed by western
blots with appropriate antibodies (see below) and developed
by the enhanced chemiluminescence method (Amersham).
Antibodies
For immunoprecipitation, we used monoclonal antibodies
against Sm proteins B/B0, D1 and D3 (Y12) (24) or against
the HA tag (Roche). Antibodies to GST-ZFP1–169 were raised
in rabbits and affinity-purified by binding to the recombinant
protein immobilized on nitrocellulose filters (15). These puri-
fied antibodies detect a single 100 kDa protein in western
blots of whole cell extract from human 293-T cells (data not
shown). Sm proteins or ZFP100 were detected in western blots
by indirect immunostaining with species-specific antibodies
(anti-mouse or anti-rabbit, respectively) coupled to horserad-
ish peroxidase (HRP) (Promega); HA-tagged proteins were
detected directly with anti-HA antibody (Roche) coupled
to HRP.
GST pull-down assays with HeLa nuclear extract
HeLa cells were harvested by trypsinization and nuclear
extracts were prepared as described previously (15). The nuc-
lear extracts were incubated with immobilized recombinant
GST (negative control) or GST-ZFP1001–169 (1.2 nmol
each) for 2 h as described above. The beads were then washed
and split into two equal portions. One half of the beads was
subjected to 12% SDS–PAGE and western blotting with Y12
anti-Sm and anti-Lsm11 antibodies (16). The other half of
the beads was used for RNA extraction at 65C with a buffer
containing 10 mM Tris–HCl, pH 8, 5 mM EDTA, 0.5% SDS,
1 mg proteinase K and 4 mg glycogen. The obtained RNAs
were extracted twice with phenol:chloroform:isoamyl alcohol,
followed by an ethanol precipitation. Reverse transcriptions
were then performed with the StrataScript RT system (Strata-
gene) and specific 30 primers for U1, U2 and U7 snRNAs
(Table 2). A subsequent PCR was performed with Taq poly-
merase (Roche) and the specific primers listed in Table 2. RT
and PCR conditions were selected for each primer pair and are
available on request.
Processing experiments
The functionality of Lsm11 mutants in histone RNA 30 end
processing was tested by an assay involving a chimeric histone
pre-mRNA/U7 snRNA molecule (called 12/12-U7 RNA) that
was injected into Xenopus laevis oocytes (16,25). Capped,
unlabelled mRNAs encoding various HA-tagged mLsm11
proteins were transcribed in vitro from linearized plasmids
using T7 RNA polymerase and subsequently polyadenylated
Table 1. Primers for PCR-generated deletions of ZFP100
Forward primersa Reverse primersb
M A E E F V
MAEEFV-1 (1): CGTAATACGACTCACTATAGGCCATGG CTGAGGAATTTG 4-KCN* (406)
GGATTTCCCACGTTAGTTACAC
M E K P Y Q
MEKPYQ-1 (206): CGTAATACGACTCACTATAGGCCATGG AGAAACCATATCAATG 8-GKI* (550)
GGGTTCTGATCCTAGATCTTC
M (A) T S E C Q
MATSEC-4 (374): CGTAATACGACTCACTATAGGCCATGG CTACCTCTGAGTGTCAGG 14-EKP* (757)
CATTCCTGACAAACCTAAGGC
M (E) P F E C D
MEPFEC-10 (590): CGTAATACGACTCACTATAGGCCATGG AGCCCTTTGAATGTGACC STOP+30 (871)
CATATTCTGGGACTCTGCTGC
M E K P Y V C
MEKPYV-15 (755): CGTAATACGACTCACTATAGGCCATGG AAAAGCCTTATGTTTGTC
aThe forward primers are named according to the first five amino acids, the first intact zinc finger repeat (after the hyphen) and the first amino acid number (in brackets)
of ZFP100 which are encoded by the respective translation product. These primers each contain a T7 RNA polymerase promoter followed by an in-frame start codon
(bold underlined). Aminoacids shownin bracketswere alteredwith respect to the naturalZFP100sequenceso that the start codoncould be followedbya G residue (27).
bThe internal reverse primers are designated with respect to the last intact zinc finger repeat (preceding the hyphen), the last three amino acids preceding the stop
codon (asterisk), and the last amino acid of ZFP100 encoded by the respective translation product (in brackets). In-frame stop codons were introduced with the primers
(bold underlined). STOP+30 (871) designates a primer complementary to a sequence downstream of the natural stop codon.
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using yeast poly(A) polymerase (USB Corp./Amersham)
according to the manufacturer’s instructions. The mRNAs
were injected into the oocyte cytoplasm, followed by incuba-
tion at 18C for 20 h to allow for protein expression.
After a second cytoplasmic injection with capped and
radiolabelled chimeric 12/12-U7 RNA, the oocytes were fur-
ther incubated for 3 h. Oocyte extracts were prepared and
subjected to immunoprecipitations with anti-Sm (Y12) or
anti-HA antibodies. RNA from the pellet fraction was
recovered by phenol extraction and analysed on a 12% dena-
turing polyacrylamide gel. As control, the HA-tagged proteins
were analysed for expression and for incorporation into
snRNPs by western blotting with anti-HA antibody with or
without prior immunoprecipitation with Y12 antibody.
RESULTS
The N-terminus of Lsm11 binds to the zinc finger
repeats of ZFP100
Dominski, Marzluff and co-workers (14) have shown that U7
snRNA can be immunoprecipitated from nuclear extracts
by anti-ZFP100 antibodies, suggesting that an interaction
between these two components of the histone RNA processing
machinery exists in vivo. More specifically, we have demon-
strated the ability of the N-terminus of Lsm11 to interact with
ZFP100 in vitro (16). Here, we attempted to map the region
within ZFP100 that is responsible for this interaction by using
the same methodology. In other words, we analysed the pre-
cipitation of in vitro translation products corresponding to
various parts of ZFP100 (Figure 1A) with either GST-
mLsm11N136 (the N-terminal extension of Lsm11 fused to
GST) or GST (negative control) which were immobilized
on glutathione sepharose beads.
We initially tested the binding of ZFP100 fragments that
had been obtained by restriction fragment subcloning. One of
these, the near FL protein ZFP1–855, had already been used in
our previous study (16). In agreement with the results obtained
there, ZFP1–855 was precipitated by GST-mLsm11N136 but not
by GST (Figure 1B). When ZFP1–855 was subdivided into two
parts, the N-terminus devoid of zinc fingers but containing a
Kru¨ppel-associated box (KRAB) domain (ZFP1–169) and the
C-terminal part encompassing all but the last of the zinc
fingers (ZFP169–855) behaved differently. The zinc finger-
containing fragment ZFP169–855 bound efficiently to GST-
mLsm11N136, whereas the N-terminal ZFP1–169 showed no
binding. Moreover, none of the proteins showed any binding
to GST alone. These results indicated that the binding site of
ZFP100 for the Lsm11 N-terminus resides in the zinc finger
repeat region.
To locate the binding site for the Lsm11 N-terminus more
precisely, we amplified various parts of the ZFP coding
sequence using forward primers equipped with T7 promoters
and translation start codons and reverse primers introducing
premature stop codons or a reverse primer annealing to a
sequence downstream of the natural ZFP100 stop codon
(Table 1, Figure 1 and Materials and Methods). These PCR
products were cloned, the resulting plasmids were subjected to
coupled in vitro transcription/translation, and the 35S-labelled
translation products were tested for their binding activity.
Surprisingly, all these truncated proteins bound to immobil-
ized GST-mLsm11N136 but not to GST, although the binding
seemed to be less efficient for some shorter polypeptides, e.g.
ZFP374–550 (Figure 1C). This suggested that the binding was
not associated with a specific subset of zinc fingers, but that
any combination of zinc finger repeats (fragments contain-
ing as few as four repeats were tested) could bind to the
N-terminus of Lsm11. As a control for specificity, we tested
Kid-1 (ZNF354A), a renal transcription factor from the rat
which, like ZFP100 (ZNF473), is a member of the large family
of KRAB domain-containing C2H2 zinc finger proteins (26).
The two proteins share 40% amino acid identity and an
additional 15% similarity over their entire length with the
zinc finger regions being somewhat more related. We found
that Kid-1 also bound to immobilized GST-mLsm11N136 but
not to GST (Figure 1D). In contrast, Sm D2 did not bind to
GST-mLsm11N136 (data not shown). Thus, it appears that the
N-terminus of Lsm11 has a general affinity for C2H2 zinc
finger domains.
A second interaction can be formed between
the N-terminus of ZFP100 and proteins
containing an Sm domain
As the N-terminus of ZFP100 showed no binding to the
N-terminus of Lsm11, we wanted to know whether it could
interact with other parts of Lsm11. For this purpose, GST-
ZFP1–169 or GST (negative control) was immobilized on gluta-
thione beads and incubated with in vitro translation products
corresponding to various parts of Lsm11 (Figure 2A).
These experiments indeed revealed that GST-ZFP1–169, but
not GST alone, could bind to mLsm11FL (Figure 2B, top
panel). In contrast, GST-ZFP1–169 did not bind to the
Lsm11 N-terminus (mLsm11N136; third panel), confirming
the result of the reciprocal experiment shown in Figure 1B.
As expected from this result, GST-ZFP1–169 also bound effi-
ciently to a deletion of Lsm11 lacking the N-terminus
(mLsm11D140; second panel). Furthermore, deleting 77
amino acids from the spacer separating the two Sm motifs
of Lsm11 (mLsm11Dsp77) still allowed for binding to GST-
ZFP1–169 (bottom panel).
These results indicated that the C-terminal half of Lsm11
containing the two Sm motifs was the main interaction site
for GST-ZFP1–169. We, therefore, wanted to see whether this
interaction was specific for Lsm11 or whether it could also
occur with another Sm/Lsm protein. Thus, we analysed
Sm D2, which is a component of spliceosomal snRNPs
but not of U7 snRNPs, for its binding to GST-ZFP1–169.
Table 2. Primers for RT–PCR of U1, U2 and U7 snRNAs
snRNA Primer Sequence
U1 hU1 50 50-ATACTTACCTGGCAGGGGAGATACCATGAT-
CACG
hU1 30 50-CAGGGGAAAGCGCGAACGCAGTCCCCCAC-
TACC
U2 hU2 50 50-ATCGCTTCTCGGCCTTTTGGCTAAGATCAAG
hU2 30 50-GTGCACCGTTCCTGGAGGTACTG
CAATACC
U7 hU7 50 50-GCATAAGCTTAGTGTTACAGCTCTTTTAGAA
TTTGTC
hU7 30 50-CGTAGAATTCAGGGGCTTTCCGGTAAAAAG
CCAG
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Surprisingly, Sm D2 also efficiently bound to GST-ZFP1–169,
but not to GST alone (Figure 2C). This result suggested
that the ZFP100 N-terminus primarily binds to Sm
domains without discriminating between different Sm/Lsm
proteins, at least not between Lsm11 and Sm D2. As we
have shown above that the N-terminus of Lsm11 binds to
ZFP100’s zinc fingers, but not to its N-terminus (Figure 1),
this means that the two proteins can make two separate binding
contacts.
Four phylogenetically conserved sequences in the
N-terminus of Lsm11 are not important for
ZFP100 binding
Since the N-terminus of Lsm11 that interacts with the zinc
finger repeats of ZFP100 (16) (Figure 1) contains four
patches of phylogenetically conserved amino acids (22)
(see our Lsm11 database at http://www.izb.unibe.ch/
res/schuehome/schuemperli/Lsm11.html), we decided to
Figure 1. The N-terminus of Lsm11 (GST-mLsm11N136) binds to the C2H2 zinc finger repeats of ZFP100. (A) Structure of ZFP100. Dark grey box labelled ‘K’,
KRAB domain; light grey boxes, C2H2 zinc finger repeats; imperfect repeats are delineated by stippled lines. (B) GST pull-down assays with ZFP1–855, ZFP169–855
and ZFP1–169 encoded by subcloned NcoI and NcoI/XhoI restriction fragments as indicated in (A). (C) GST pull-down assays performed with ZFP100 truncations
obtained by PCR (see Materials and Methods). The numbers indicate the ranges of amino acids of FL ZFP100 that are present in the various truncations. (D) GST
pull-down assay performed with the C2H2 zinc finger protein Kid-1, a renal transcription factor from rat that is not related to histone RNA processing. All templates
were linearized and subjected to coupled in vitro transcription/translation in the presence of [35S]methionine. The translation products were incubated with GST-
mLsm11N136 or GST (negative control) immobilized on glutathione sepharose beads. The beads were washed, and the bound material was analysed by SDS–PAGE
and autoradiography. Input, 1/10 the amount used in the binding assays was analysed directly. Note that only ZFP1–169 encoding the N-terminus of ZFP100 lacking
zinc finger repeats but containing the KRAB domain does not bind to GST-mLsm11N136, whereas all fragments encoding zinc finger repeats bind efficiently.
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investigate whether any of these sequences are required
for binding to ZFP100. To this end, three consecutive
amino acids in each conserved sequence were converted to
alanines (Figure 3A) in the context of a vector containing the
Lsm11 open reading frame fused in frame to an N-terminal
HA tag. We then analysed whether the HA-tagged mutant
proteins, when translated in vitro in reticulocyte lysate, could
still be precipitated by GST-ZFP1–169 bound to glutathione
sepharose beads. Indeed, all four mutant proteins were pre-
cipitated as well as the wild-type FL protein (Figure 3B,
compare lanes 9–12 with 7). This was an expected finding
for three of the mutants, because the mutated sequences were
within the region deleted in HA-mLsm11DN140, and the
latter showed full binding to GST-ZFP1–169 (lane 8).
However, the MPL mutant, which is located downstream
of amino acid 140, also showed normal binding to the
N-terminus of ZFP100 (Figure 3B, lane 12). Thus, we con-
clude that one of the two interactions between Lsm11 and
ZFP100, which links the N-terminus of ZFP100 to the Sm
domain of Lsm11, is not affected by any of the clustered
point mutations.
Then, we analysed whether the other interaction, taking
place between the N-terminus of Lsm11 and the zinc finger
region of ZFP100, was affected in any of these mutants. To
this end, we cloned N-terminal fragments from each
mutant into pGex4T3 to produce and purify GST-tagged
proteins in E.coli. For the PLL, YES and PER mutations,
the resulting proteins corresponded in size to GST-
mLsm11N136. However, as the MPL site is located down-
stream from amino acid 136, we cloned the MPL mutation
and an equivalent wt control as a fragment corresponding to
amino acids 1–157. All these GST-tagged proteins were used
in GST pull-down assays to analyse the binding of in vitro
translated ZFP1–855 or ZFP169–855.
The results of these binding assays indicated no significant
reduction with three of the mutants (Figure 3C, lanes 4, 5 and
8). In contrast, the binding of the PER > AAA mutant to both
ZFP1–855 and ZFP169–855 was slightly reduced (lane 6). How-
ever, additional experiments in which the amounts of GST
fusion proteins recovered after the precipitation and washing
steps were monitored by Ponceau red staining indicated that a
lower amount of PER mutant protein had been used, although
identical amounts based on Lowry assay results had been
pipetted (data not shown). Thus, we conclude that none of
the four mutants significantly affects either type of binding
to ZFP100.
The failure to detect an effect of these mutations on
the interaction with ZFP100 could have been due to the
binding conditions used to perform the binding assays (see
Materials and Methods), in particular the large excess of GST-
tagged N-termini of Lsm11 compared with the in vitro trans-
lated proteins. However, when the binding assays presented in
Figure 3C were repeated with a smaller (40-fold) molar excess
of GST-tagged proteins, identical results were obtained (data
not shown). Moreover, experiments shown in Figure 4B below
demonstrate that the four mutant proteins, after in vivo expres-
sion, still interact with ZFP100.
Determinants of ZFP100–U7 snRNP interactions
in cellular extracts
Several of the above observations motivated us to further
analyse these interactions in cellular extracts. In particular,
we wanted to determine whether both interactions play a
role for the recognition between ZFP100 and the U7
snRNP. For example, it was unclear whether the N-
terminus of ZFP100 could only recognize monomeric Sm
domains or whether it could bind to fully assembled
Figure 2. The N-terminus of ZFP100 binds to the C-terminal Sm domain of Lsm11. (A) Structure of various constructs containing murine Lsm11. An HA-tag
introduced at the N-terminus and the Sm motifs are shown in dark grey and black, respectively. (B) GST pull-down assays. The 35S-labelled Lsm11 (FL) and its
mutants were generated in reticulocyte lysate and incubated with equal amounts of GST or GST-ZFP100 N-terminal fragment (GST-ZFP1–169). (C) GST pull-down
assay with HA-tagged Sm D2. The bound 35S-labelled proteins were analysed by SDS–PAGE and detected by PhosphorImager. Input, 1/10 the amount used in the
binding assays. Note that only N136 does not bind to GST-ZFP1–169, whereas all fragments encoding the two Sm motifs bind efficiently.
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Sm/Lsm rings. Moreover, it was important to investigate
whether the apparent promiscuity for other proteins containing
similar domains (Sm or C2H2 zinc finger domains, respect-
ively) that had been observed under these in vitro conditions
could also be seen in cellular extracts.
Thus, we expressed different HA-tagged versions of Lsm11
or other Sm proteins in 293-T cells by transient transfection
and analysed the ability of anti-ZFP100 antibodies to co-
immunoprecipitate these HA-tagged proteins from whole
cell extracts. The full-length HA-mLsm11FL was readily
precipitated by the anti-ZFP100 antibodies (Figure 4A, top
panel, lane 3) (data not shown), whereas protein G sepharose
beads either alone (lane 2) or coupled to unrelated antibodies
(data not shown) did not precipitate HA-mLsm11FL. This con-
firmed previous findings of Dominski, Marzluff and co-
workers (14) who showed that a different anti-ZFP100 anti-
body could co-precipitate U7 snRNA from HeLa cell nuclear
extract. We similarly expressed and analysed HA-tagged
mLsm11D140, which should be able to form only one of the
two interactions characterized above. Despite the fact that this
protein lacks the N-terminus and is non-functional in histone
RNA processing [see below and (16)], it still gets incorporated
into U7 snRNPs in vivo (16). Interestingly, HA-mLsm11D140
was also precipitated by the anti-ZFP100 antibodies
(Figure 4A, second panel, lane 3).
Since the interactions in these extracts could be mediated by
the base pairing between histone pre-mRNA and U7 snRNA,
we also analysed the precipitation of the same two HA-tagged
proteins from extracts that had been treated with RNase A. For
both proteins, the precipitation by the anti-ZFP100 antibodies
was less efficient than in extract incubated in the absence of
RNase A (Figure 4A, compare lanes 6–3). This suggested that
the interaction was strongly enhanced by RNA, presumably
by the histone pre-mRNA and U7 snRNA. Nevertheless,
both proteins still showed a residual co-precipitation with
ZFP100. In particular, the residual co-precipitation of
HA-mLsm11D140 suggested that the interaction between the
N-terminus of ZFP100 and the Sm domain of Lsm11 (and
possibly other Sm/Lsm proteins) can occur in the context of
a fully assembled snRNP and may contribute to the binding
between ZFP100 and the U7 snRNP in cell extracts.
To investigate the specificity of these interactions, we ana-
lysed HA-tagged versions of either Sm D2 or of a fusion
between the N-terminus of Lsm11 and D2 (N136-D2) by
the same assay. Both of these proteins associate with U1,
but not with U7, snRNA in vivo (16). Neither of these proteins
could be precipitated by anti-ZFP100 antibodies (Figure 4A,
two lower panels). This indicated that ZFP100, in extracts,
specifically interacts with U7 snRNPs containing either full-
length or N-terminally truncated Lsm11, but not with spliceo-
somal snRNPs, even if these contain Sm D2 fused to the
Lsm11 N-terminus. This latter finding indicated that the inter-
action between the zinc finger repeats of ZFP100 and the
N-terminus of Lsm11 may be relatively inefficient in such
extracts or may require additional determinants on the U7
snRNP.
We also wanted to confirm by an independent approach that
the clustered point mutations in the conserved N-terminal
regions of Lsm11 introduced in Figure 3 above do not affect
the binding to ZFP100. We, therefore, expressed wild-
type HA-Lsm11 and all four mutant proteins by transient
transfection of 293-T cells and analysed the ability of anti-
ZFP100 antibodies to co-immunoprecipitate these HA-tagged
proteins. As shown in Figure 4B, none of the mutants had a
significant effect on the interaction of Lsm11 with ZFP100 as
detected by this binding assay.
As a further test for the interactions between Lsm11 and
ZFP100, we subjected HeLa cell nuclear extracts to GST pull-
down assays. With GST-mLsm11N136-coated glutathione
beads, only trace amounts of ZFP100 could be precipitated
Figure 3. Conserved amino acid sequences in the N-terminus of Lsm11 are not
important for binding to ZFP100. (A) Mutagenesis of four phylogenetically
conserved amino acid sequences in the N-terminus of Lsm11 (22) (see
our Lsm11 database at http://www.izb.unibe.ch/res/schuehome/schuemperli/
Lsm11.html). Amino acids that were mutated to alanines in the murine Lsm11
cDNA are underlined and the amino acid position of the first one is indicated.
The mutants were named according to the original sequence (i.e. PLL,
YES . . . ). (B) The 35S-labelled Lsm11 (FL) and its mutants were generated
in reticulocyte lysate and incubated with equal amounts of GST (data not
shown, but no signals were obtained) or GST-ZFP100 N-terminal fragment
(GST-ZFP1–169). For a description of the Lsm11 FL and DN140, see Figure 2A.
(C) The 35S-labelled ZFP fragments ZFP1–855 (upper panel) and ZFP169–855
(lower panel) were generated in reticulocyte lysate and incubated with beads
loaded with GST (lane 2) or GST-tagged Lsm11 amino acids 1–136 (lanes 3–6)
or 1–157 (lanes 7,8) that contained either the wt sequence or the indicated
mutations.
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from the extract, barely more than with beads coupled to GST
alone (data not shown). In contrast, GST-ZFP1–169-coated
glutathione beads efficiently precipitated Lsm11 (Figure 4B,
top panel, lane 3) and Sm B/B0, but not Sm D1 from the
extracts (second panel, lane 3), indicating that U7 snRNPs,
but not spliceosomal snRNPs, were being precipitated. No
precipitation was seen with beads coupled to GST (top two
panels, lane 2). RT–PCR assays performed on RNA isolated
from the precipitates indicated that U7, but not U1 or U2,
snRNA was being precipitated by the GST-ZFP1–169-coated
beads (Figure 4B, lower three panels). These results are
consistent with the above co-immunoprecipitation experi-
ments in demonstrating that the N-terminus of ZFP100 can
specifically bind to the U7 snRNP in cell extracts.
Three of the phylogenetically conserved N-terminal
motifs of Lsm11 are important for histone RNA
processing
Since the N-terminus of Lsm11, in addition to its interaction
with ZFP100, fulfils an essential function in histone RNA 30
end processing (16), and it contains the four patches of
phylogenetically conserved amino acids described above,
we decided to investigate whether any of these sequences
are required for processing. To this end, capped and poly-
adenylated mRNAs encoding full-length, HA-tagged Lsm11
with either the wt sequence or with a triple alanine mutation in
one of the conserved motifs (see Figure 3A) were synthesized
in vitro and injected into Xenopus oocytes. After overnight
incubation to allow for translation, a capped, radiolabelled
chimeric RNA consisting of a histone pre-mRNA sequence
fused to a U7 snRNA moiety (25) (Figure 5A) was injected
into the same oocytes. Three hours later, oocyte extracts were
prepared, the HA-tagged proteins were precipitated and the
associated chimeric RNA was analysed by denaturing gel
electrophoresis.
The rationale of this assay is that processing of the chimeric
RNA depends on the assembly of a U7-specific Sm/Lsm core
at the Sm-binding site of the U7 snRNA moiety (16,25). If the
RNA associated with a given HA-tagged Lsm11 protein has
been cleaved in the oocyte, this means that the protein is
functional in histone RNA processing, because all the other
proteins of the processing complex will be wt Xenopus
proteins.
In agreement with our previous experiments (16), wild-
type HA-mLsm11FL formed RNPs with the chimeric
RNA that were functional in histone RNA processing
(Figure 5B, lane 3), whereas the HA-mLsm11DN140 mutant
with most of the N-terminal extension deleted was non-
functional (lanes 5 and 8). Of the four clustered point muta-
tions, the MPL mutant (lane 11) was similarly deficient in
histone RNA processing as the N-terminal deletion. Moreover,
the PLL (lane 9) and PER (lane 4) mutants showed a reduced
processing efficiency. In contrast, the YES mutant (lane 10)
supported processing of the chimeric RNA with a similar
efficiency as the wt protein. A quantitation of the results aver-
aged over 2–3 independent assays for each of these proteins is
shown in Figure 5C.
Figure 4. Determinants of ZFP100–U7 snRNP interactions in mammalian cell extracts. (A) The various HA-tagged proteins indicated on the left were expressed in
human 293-T cells by transient transfection. Whole cell extracts were subjected to immunoprecipitation with affinity-purified antibodies directed against the
N-terminal 169 amino acids of human ZFP100 (a-ZFP). The samples were subjected to SDS–PAGE, blotted, and the HA-tagged proteins were revealed by anti-HA
antibody. For the two top panels, the extracts were incubated in the absence (lanes 1–3) or presence of RNase A (lanes 4–6) prior to immunoprecipitation (see
Materials and Methods). The samples for each protein were processed in the same experiment and analysed on the same gel, but an intermediate lane was excised from
the picture. FL, full-length murine Lsm11 (HA-mLsm11FL); DN140, mLsm11 lacking the first 140 amino acids (HA-mLsm11D140); N136-D2, first 136 amino acids
of mLsm11 fused to Sm D2 (16). Beads, precipitation by protein G sepharose beads without antibody; input, 1/20 of original extract. (B) Wild-type HA-tagged Lsm11
and the clustered point mutants indicated on the right (for their sequence see Figure 3) were expressed in human 293-T cells and their ability to interact with ZFP100
was assessed by immunoprecipitation with a-ZFP as in (A). (C) Nuclear extract from HeLa cells was subjected to precipitation with glutathione beads coupled to
GST-ZFP1–169 (lane 3) or GST alone (lane 2) and analysed for several snRNP components as indicated on the right. Lsm11 was detected by affinity-purified anti-
Lsm11 antibodies (16); Sm B/B0 and D1 by the monoclonal anti-Sm antibody Y12; and snRNAs U1, U2 and U7 by RT–PCR as described in Materials and Methods.
Input, 1/10 of original extract.
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Notably, the precipitated HA-mLsm11MPL mutant protein
was associated with uncleaved chimeric RNA (Figure 5B, lane
11), indicating that although it was deficient in histone RNA
processing, it could still form an RNP complex along with the
other six members of the U7-specific Sm core. To analyse this
more directly, HA-mLsm11MPL was transiently transfected
into human 293-T cells. A whole cell extract from these
cells was then precipitated with magnetic streptavidin beads
after the addition of biotinylated oligonucleotides comple-
mentary to either U7 or U1 snRNAs or without oligonuc-
leotide (as a negative control). Indeed, HA-mLsm11MPL
was found to be associated with U7, but not with U1
snRNA or beads alone, in a complex with SmB/B0 (Figure
5D). Thus, it behaved similarly as the wild-type HA-
mLsm11FL protein and different truncation mutants that con-
tain an intact C-terminal Sm domain (16). Taken together, this
means that the MPL > AAA mutation causes a complete loss
of processing activity, but does not affect the assembly of the
protein into the U7 snRNP. In addition, the PLL > AAA and
PER > AAA mutations cause a partial loss of processing
activity.
DISCUSSION
Characterization and relative importance of two
separate interactions between Lsm11 and ZFP100
One of the aims of this study was to characterize the interac-
tion between the N-terminus of Lsm11 and ZFP100 that we
had recently discovered (16). Now, our in vitro binding ana-
lyses have revealed that the interaction between these two
proteins is more complex than anticipated. On the one
hand, we could show that this interaction between the N-
terminus of Lsm11 and ZFP100 is directed towards the latter’s
zinc finger repeats, but cannot be pinpointed to a specific set of
zinc fingers (Figure 1). Rather, the fact that an interaction can
also be observed with the unrelated Kid-1 protein suggests that
the binding is directed towards C2H2 zinc finger repeats in
general. Thus, within ZFP100, the various zinc finger repeats
can be regarded as redundant binding sites for the N-terminus
of Lsm11. Interestingly, the HBP/hairpin complex also inter-
acts with this region of the protein. Dominski, Marzluff and
co-workers (14) have localized the region of ZFP100 that
efficiently interacts with the HBP/hairpin complex to the
Figure 5. Three conserved amino acid sequences in the N-terminus of Lsm11 are important for histone RNA 30 end processing. (A) The chimeric histone–U7 RNA
[12/12-U7 RNA (25)] used in (B) contains 49 nt of histone pre-mRNA upstream and 36 nt downstream of the cleavage site (vertical arrow), a connector segment of 28
and 65 nt of U7 RNA sequence. The Sm-binding site is indicated by a black bar. (B) Processing of chimeric histone–U7 RNA in Xenopus oocytes. Synthetic mRNAs
encoding HA-tagged versions of mLsm11FL (wt) or of the four mutants (see Figure 3A) were injected into the cytoplasm of X.laevis oocytes. RNA encoding
HA-tagged Lsm11 lacking the first 140 amino acids (DN140) was injected as a processing-deficient control (16). After overnight incubation to allow for translation of
the recombinant proteins, the oocytes were challenged with radiolabelled, chimeric histone–U7 RNA [see (A)]. In the oocytes, this RNA gets cleaved at the histone
RNA processing site, dependent upon assembly of a functional Sm/Lsm core at its Sm-binding site. Oocyte extracts were subjected to immunoprecipitation with
either Y12 anti-Sm or anti-HA antibodies to enrich for total snRNPs or for particles containing HA-tagged Lsm11, respectively. The radiolabelled RNA was analysed
by denaturing polyacrylamide gel electrophoresis and autoradiography. Lanes 2 and 6, HA-mLsm11FL extract (wt) precipitated with beads lacking antibody.
(C) Quantitation of the ratios of 30 processing product:total chimeric RNA determined by PhosphorImager scanning. The results represent averages of 2–3
independent determinations for each construct. Note that the MPL mutant and the N-terminal deletion show a strong defect in processing, but still associate with
the chimeric RNA. The PLL and PER mutants are partly deficient in processing. (D) The MPL mutant protein is associated with U7 snRNA in mammalian cell
extracts. Whole cell extract from human 293-T cells transiently transfected with the plasmid encoding HA-mLsm11MPL was incubated with biotinylated oligo-
nucleotides complementary to the 50 ends of either U7 or U1 snRNA and precipitated with magnetic streptavidin beads. The samples were subjected to SDS–PAGE
and immunoblotted with anti-HA antibody to detect the HA-mLsm11MPL protein and with Y12 antibody to detect the Sm B/B0 protein as a precipitation control.
Beads, precipitation by beads without oligonucleotide; input, 1/10 of original extract. The two panels are taken from the same gel, but an intermediate lane was
excised from the picture.
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zinc fingers 2–8 (see Figure 6). Additionally, certain shorter
truncations of this region had a reduced binding activity. If
their mapping is correct, then the zinc finger repeats 2–8 may
not be able to interact with Lsm11 in the context of a HBP–
ZFP100–U7 snRNP complex.
On the other hand, we show here that the N-terminus of
ZFP100, which lacks zinc finger domains, can also bind
Lsm11 (Figure 2). This region of ZFP100 interacts with the
Sm domain but not with the N-terminus of Lsm11. Moreover,
this binding is not specific for Lsm11, because Sm D2, an Sm
protein that does not normally occur in the U7 snRNP (15,16),
can also bind to the ZFP100 N-terminus (Figure 2C).
Thus, we are faced with the fact that these two proteins
involved in histone RNA processing can undergo not only one
but two interactions, and that neither of them is completely
specific for the respective binding partner. To simplify the
following discussion, we will henceforth call the first interac-
tion A and the second one B (Figure 6).
Unfortunately, it was technically not possible to determine
relative affinities for these interactions. Despite intensive
efforts, any recombinant proteins containing either the zinc
fingers of ZFP100 or the Sm domain of Lsm11 were insoluble,
so that we could only work with the small amounts of protein
that could be translated in vitro. This meant that all in vitro
binding reactions were carried out with an excess of either
GST-mLsm11N136 or GST-ZFP1–169, both of which could be
obtained as soluble proteins in E.coli. In order to gain more
insight into the relevance of these interactions, we therefore
investigated whether they could be observed in cell extracts
and whether, under these conditions, they would also be relat-
ively non-specific for the respective binding partner. More-
over, for the interaction B, this approach helped us determine
whether the ZFP100 N-terminus can recognize Sm domains
in the context of fully assembled Sm/Lsm cores or whether it
binds to them only as individual subunits.
No strong evidence that the interaction A occurs in cell
extracts could be obtained. A precipitation of HeLa nuclear
extract with GST-mLsm11N136-coated glutathione beads
contained only very low amounts of ZFP, barely more
than was precipitated by GST alone (data not shown). In
contrast, GST-ZFP1–169-coated glutathione beads efficiently
precipitated U7 snRNPs, but not spliceosomal ones, from
the nuclear extract (Figure 4B). This experiment proved
that the N-terminus of ZFP100 that binds to Sm domains
can do so in the context of fully assembled Sm/Lsm cores
and, moreover, specifically recognizes the U7 snRNP in nuc-
lear extracts. We also observed a specific recognition of the U7
snRNP by ZFP100 in our co-immunoprecipitation experi-
ments with anti-ZFP100 antibody (Figure 4A) in agreement
with previous results by Marzluff, Dominski and co-workers
(14). Our further findings with this immunoprecipitation assay
indicated that this interaction does not require the presence
of the N-terminus of Lsm11 and that spliceosomal snRNPs
containing a fusion between the N-terminus of Lsm11 and Sm
D2 are not recognized. Although the interaction between
ZFP100 and the U7 snRNP detected in these experiments
was strongly stimulated by RNA (presumably reflecting the
U7 snRNA:histone pre-mRNA interaction), a weaker binding
persisted even after an RNAse treatment, indicating that the
interaction between ZFP100 and the Sm core of the U7 snRNP
does play a role under these conditions.
All these results strongly suggest that it is primarily the
interaction B, occurring between the N-terminus of ZFP100
and the Sm domain of Lsm11 and possibly other Sm/Lsm
proteins, which is responsible for the recognition of the U7
snRNP and hence for stabilizing the base pairing between the
50 end of U7 snRNA and the histone HDE (Figure 6). This
leaves us with the question whether the previously identified
interaction A is at all relevant for the processing reaction. It is
apparently not affected by mutations in the most strongly
conserved amino acid sequence motifs in the Lsm11 N-
terminus (Figure 3; see below for a more detailed discussion
of the mutants). However, the interaction A might still play a
role, e.g. if the processing complex undergoes rearrangements
during the processing reaction.
It is not evident from our experiments why the interaction B,
which does not discriminate between the Sm domains of
Lsm11 and Sm D2 in vitro (Figure 2), is specific for the
U7 snRNP in nuclear extract (Figure 4B). Since we could
not measure relative in vitro binding affinities, we cannot
exclude that the ZFP100 N-terminus may have a higher affin-
ity for Lsm11 and/or Lsm10 than for the standard Sm proteins,
even though it can bind to Sm D2 when present in excess.
Another possible explanation for this additional specificity in
cell extracts is that the ZFP100 N-terminus may recognize
additional features of the U7 snRNP, e.g. certain determinants
on U7 snRNA.
Strong evidence for a ZFP100-independent function
of Lsm11 in histone RNA 30 end processing
The Lsm11 proteins from various species contain four con-
served amino acid motifs in their N-terminal regions (22).
To study the function of these phylogenetically conserved
sequences, we have analysed clustered point mutations in
each of them for their effects on histone RNA processing
and on the binding of the mutated proteins to ZFP100.
Three of these mutations (MPL, PLL and PER to AAA)
reduced the ability of the corresponding proteins to support
histone RNA 30 processing (Figure 5). Nevertheless, these
mutant proteins, and in particular the strongly deficient
MPL mutant, still associated with chimeric histone–U7
Figure 6. Model depicting the interactions between Lsm11 and ZFP100
characterized in this paper. To illustrate the interactions, Lsm11 (bottom)
has been drawn in the opposite orientation relative to ZFP100 (top). An
interaction between the zinc finger repeats 2–8 of ZFP100 and the HBP–
histone RNA hairpin complex was previously characterized by Dominski,
Marzluff and co-workers (14). The three conserved motifs in the N-terminus
of Lsm11, which are important for histone RNA processing (PLL, PER and
MPL), are shown in red, the fourth motif (YES) in grey.
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RNA in Xenopus oocytes or with U7 snRNA in mammalian
cells. Thus, the formation of a U7-specific Sm/Lsm core is not
affected by these mutations, but the mutant proteins indeed
function less well in processing.
Similar clustered point mutations in the other conserved
motif (YES to AAA) had no phenotype in any of the assays
used in this work. It is possible that more extensive mutagen-
esis could have revealed phenotypic changes for this motif as
well. Alternatively, it may have important functions in other
aspects of U7 snRNP biology that were not covered by our
assays, e.g. during U7 snRNP biogenesis or subcellular
localization.
As a first step to elucidate the roles of these important
(FDPLLALY and DPERIQRL) and essential (NVLTRMPLH)
amino acid sequence motifs, we tested whether the
mutant proteins were impaired in their ability to undergo either
of the two interactions with ZFP100 characterized in this
study. This was clearly not the case under our in vitro
binding conditions (Figure 3), but, for the reasons explained
above, affinity changes caused by the mutations can not be
excluded.
However, another argument indicates that the processing
defect of these mutant proteins is not due to an impaired
interaction with ZFP100. The processing assay used in this
study is not dependent on a stabilization of the U7
snRNA:HDE interaction by HBP and ZFP100. Since the
two RNA moieties are covalently linked, the base pairing
between the HDE and the U7 moiety is thermodynamically
favoured. Moreover, as the particular histone pre-mRNA
sequence used can form 16 bp (including G–U wobble
pairs) with U7 snRNA (9), the hybrid should be relatively
stable at the temperature of 18C at which the oocytes are
incubated. Consistent with this, we have previously found that
the processing is not affected when the histone hairpin of the
chimeric RNA is mutated such that it cannot bind to HBP
(B. Stefanovic and D. Schu¨mperli, unpublished data). Thus,
we can indeed conclude that the clustered point mutations
affect a processing function of Lsm11 that is independent
of its interaction with ZFP100.
At present, it can only be speculated what this ZFP100-
independent function of these motifs might be. Perhaps
they interact directly with the processing substrate or with
another, yet unidentified, processing factor. The availability
of the processing-deficient mutant proteins will hopefully
allow us to further elucidate this essential function of Lsm11
and the mechanism of histone pre-mRNA cleavage.
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